Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 15:51
Journey Medical Net Income (Quarterly) : -1.315M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.315M |
| June 30, 2026 | -0.312M |
| March 31, 2026 | -2.23M |
| December 31, 2025 | -1.247M |
| September 30, 2025 | -2.315M |
| June 30, 2025 | -3.796M |
| March 31, 2025 | -4.073M |
| December 31, 2024 | 1.521M |
| September 30, 2024 | -2.39M |
| June 30, 2024 | -3.361M |
| March 31, 2024 | -10.44M |
| December 31, 2023 | -2.143M |
| September 30, 2023 | 16.79M |
| June 30, 2023 | -8.363M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.14M |
| December 31, 2022 | -10.64M |
| September 30, 2022 | -10.08M |
| June 30, 2022 | -7.528M |
| March 31, 2022 | -1.378M |
| December 31, 2021 | -21.75M |
| September 30, 2021 | -10.65M |
| June 30, 2021 | -11.86M |
| March 31, 2021 | 0.268M |
| December 31, 2020 | 2.502M |
| September 30, 2020 | 0.029M |
| June 30, 2020 | 0.455M |
| March 31, 2020 | 2.297M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Talphera, Inc. | -4.018M |
| Fortress Biotech, Inc. | -8.254M |
| Relmada Therapeutics, Inc. | -13.86M |
| Turn Therapeutics, Inc. | -6.231M |
| ANI Pharmaceuticals, Inc. | 32.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 18.97M |
| Total Expenses (Quarterly) | 20.28M |
| EPS Diluted (Quarterly) | -0.0468 |
| Enterprise Value | 103.50M |
| Gross Profit Margin (Quarterly) | 63.87% |
| Profit Margin (Quarterly) | -6.93% |
| Earnings Yield | -5.63% |
| Normalized Earnings Yield | -5.630 |